PCORI Helps Patients Choose the Right Breast Cancer Treatment

choosing the right breast cancer treatment

Many women face a lack of information and understanding after their breast cancer diagnoses. Currently, women have more treatment options than ever before, and patients have the ability to review the latest findings to identify the option that fits best for their lives.

Nominating Colleagues for Nursing Awards Is a Professional Responsibility

Nominating Colleagues for Nursing Awards Is a Professional Responsibility

At two national nursing events in October 2017, ONS members received prestigious awards. You may have seen the news about them in your ONS Voice weekly emails. They did not receive these awards without the work of colleagues who prepared their nominations.

Study Finds Trends and Disparities in EOL Care for Patients With Hematologic Malignancies

Studies suggest that patients with hematologic malignancies receive more aggressive end-of-life (EOL) care than those with solid tumors. 

Multiple Myeloma Survivors Still Experience Symptoms and Psychological Concerns

Survival from multiple myeloma (MM) has improved, and more attention is required for symptom burden and psychological impact in the long-term management of this disease. Researchers assessed the incidence of self-reported pain, depression, financial and family burden, and impairment of performance status, as well as determined the correlation of total distress with survival. Joshua R. Richter, MD, at the John Theurer Cancer Center in Hackensack, NJ, discussed the findings at the ASH Annual Meeting.

Physical Activity Level Before and After Cancer Diagnosis Impacts Survival for Lymphoma

Researchers assessed the impact of physical activity levels before and after cancer diagnosis on overall survival (OS) and lymphoma-specific survival (LSS) outcomes in patients with lymphoma. They found that higher levels of physical activity during adult life and within three years of diagnosis improve survival. Priyanka Pophali, MD, at the Mayo Clinic in Rochester, MN, discussed the findings at the ASH Annual Meeting.

Better Symptom Management Is Needed for Patients With CML

Patients with chronic myeloid leukemia (CML) often experience symptoms and treatment-related adverse events (AEs) that are chronic and may require care from an interdisciplinary team. A study sought to assess symptom burden, palliative care needs, and experiences with healthcare team communication in this patient population. Alexandra K. Zaleta, PhD, at the Research and Training Institute, Cancer Support Community in Philadelphia, PA, discussed the findings at the ASH Annual Meeting.

Heart Failure Affects Long-Term Survival Among Older Women With Breast Cancer

heart failure in women with breast cancer

Research has shown that women aged 65 and older who have breast cancer experience higher rates of heart failure compared to their age-matched counterparts, ranging from 29% of women with breast cancer who received no chemotherapy to 38% of women who received treatment with anthracyclines. However, little is known about the association between heart failure and long-term survival in older women with breast cancer, and it is unclear how the relative contribution of heart failure to mortality risk varies by breast cancer stage.

Cancer Moonshot Offers Funding Opportunities

cancer moonshot funding

Since its initial announcement, the National Cancer Moonshot Initiative—dubbed the Biden Cancer Initiative—has captivated the scientific, patient advocacy, and provider communities with possibilities for advancements in cancer treatments and cures. The cancer moonshot continues to maintain bipartisan support, as all involved are committed to making a decade’s worth of progress in just half the time.

Sexual Function Varies by Some Treatments in Breast Cancer Survivors

Surgical modality and receipt of chemotherapy or radiotherapy are not associated with sexual function, as measured by the Female Sexual Function Index (FSFI). Patients receiving endocrine therapy with an aromatase inhibitor had significantly lower sexual function scores than those who received no endocrine therapy or those on tamoxifen, said a group of U.S. researchers who presented their findings during a poster session on Saturday, December 10, at the San Antonio Breast Cancer Symposium.

Latinas With BRCA1 or 2 Mutations Are More Likely to Choose Surgery

The uptake of prophylactic surgeries among Latinas with germline BRCA mutations may be slightly lower than what has been reported in non-Hispanic whites but higher than in African Americans, a group of U.S. researchers said. They presented their findings on Saturday, December 10, during a poster session at the San Antonio Breast Cancer Symposium.

Subscribe to